Michael Furrow’s experience with and understanding of the challenges innate to discovery in the pharmaceutical and biotechnology fields fuels his passion to enforce and defend life sciences patents. He has represented innovators across these industries in high-stakes patent disputes both in Federal Court and before the U.S. Patent and Trademark Office, concerning drugs or biologics for treating HIV/AIDS, Alzheimer’s disease, breast cancer, prostate cancer, bacterial infection, epilepsy, and various endocrine, vascular and gastrointestinal diseases, as well as genetically modified animals. Michael’s experience covers all aspects of life sciences innovation, including new chemical entities, salt forms, prodrugs, solid state forms, dosage forms, combination products, methods of use, biologics and laboratory tools. In addition to his work in contested matters, he also has experience providing opinions on infringement and validity issues, and conducting due diligence in connection with patent-related business transactions.
Michael joined Fitzpatrick directly out of law school. He has published several articles in in the field of organic chemistry.Additional Publications
“Cost-Containment Strategies for Patentees in Litigation,” Lexis Practice Advisor®
"Protecting Deuterated Drugs,"
Intellectual Property Magazine, 2018
"Strategies for Overcoming Early Litigation Challenges to Patent Eligibility,”
Lexis Practice Advisor®
"Pharmaceutical Patent Life-Cycle Management after KSR v. Teleflex," Food and Drug Law Journal, 2008.
"A General Procedure for the Esterification of Carboxylic Acids with Diazo-alkanes Generated In Situ by the Oxidation of N-tert-Butyldimethylsilylhydrazones with (Difluoroiodo) benzene," Journal of the American Chemical Society, 2004.
"Practical Procedures for the Preparation of N-tert-Butyldimethylsilyl-hydrazones and Their Use in Modified Wolff-Kishner Reductions and in the Synthesis of Vinyl Halides and gem-Dihalides," Journal of the American Chemical Society, 2004.
"Highly Selective Hydrolytic Kinetic Resolution of Terminal Epoxides Catalyzed by Chiral (salen) CoIII Complexes. Practical Synthesis of Enantioenriched Terminal Epoxides and 1,2-Diols," Journal of the American Chemical Society, 2002.
"Practical Access to Highly Enantioenriched C-3 Building Blocks via Hydrolytic Kinetic Resolution," Journal of Organic Chemistry, 1998.
"Practical Synthesis of Enantiomerically Enriched Glycidol by Kinetic Resolution of (±)-Epichlorohydrin and Dynamic Kinetic Resolution of (±)-Epibromohydrin," The Nucleus, 1998.